Compare Intercontinental Exchange Inc. Common Stock (ICE) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intercontinental Exchange Inc. Common Stock vs Neurocrine Biosciences Inc — how do they compare? Intercontinental Exchange Inc. Common Stock trades at $156.85 (market cap $87.21B), while Neurocrine Biosciences Inc trades at $142.7 (market cap $14.36B). The key difference: Intercontinental Exchange Inc. Common Stock is far larger — about 6.1× Neurocrine Biosciences Inc's market cap, and Intercontinental Exchange Inc. Common Stock pays a 1.34% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| ICE | NBIX | |
|---|---|---|
Market Cap | $87.21B | $14.36B |
Volume | 2,029,112 | 1,237,180 |
Sector | Financials | Health |
52-Week High | $175.10 | $185.50 |
52-Week Low | $122.91 | $123.10 |
Enterprise Value | $105.12B | $14.37B |
Dividend Yield | 1.34% | — |
Typical Hold Time | — | 23 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Neurocrine Biosciences (NBIX) trades at $141.69, down 1.24% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 20.91% net income margin and consistent earnings beats, including a significant Q2 2026 beat. Recent news highlights pipeline advancements and executive appointments, while analyst sentiment remains overwhelmingly positive.
The outlook for NBIX is supported by robust fundamentals and strong analyst buy ratings, but near-term price action is challenged by technical bearishness. Key opportunities include product diversification and pipeline growth, while risks involve execution of expansion plans and potential pricing pressures on key products like INGREZZA.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intercontinental Exchange Inc. Common Stock
Intercontinental Exchange provides technology and data services for financial institutions, corporations, and governments. Its businesses include exchanges and clearing, fixed-income data and analytics, and mortgage technology.
Read more on ICE →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
